Clinical trial

Semaglutide and Vascular Regeneration

NCT05870462

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-04-29

PhasePHASE4

Study timeline

Study start (actual)2023-04-29Date precision: day

Registry last updated2023-07-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Atherosclerosisunresolved

Cardiovascular Diseasesunresolved

Diabetes Mellitus, Type 2unresolved

Obesityunresolved

Interventions

Semaglutide Pen InjectorDRUG · verified · RxNorm: semaglutide Pen Injector

Sponsors & collaborators

Canadian Medical and Surgical Knowledge Translation Research Grouplead sponsor

Unity Health Torontocollaborator

Western University, Canadacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05870462 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.